% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Lamoureux:296022,
author = {A.-A. Lamoureux and M. J. Fisher and L. Lemelle and E.
Pfaff$^*$ and P. Amir-Yazdani and C. Kramm and B. De Wilde
and B. Kazanowska and C. Hutter and S. Pfister$^*$ and D.
Sturm$^*$ and D. Jones$^*$ and D. Orbach and G. Pierron and
S. Raskin and A. Drilon and E. L. Diamond and G. Harada and
M. Zapotocky and J. Zamecnik and L. Krskova and B. Ellezam
and A. G. Weil and D. Venne and M. Barritault and P. Leblond
and H. Coltin and R. Hammad and U. Tabori and C. Hawkins and
J. R. Hansford and D. Meyran and C. Erker and K. McFadden
and M. Sato and N. G. Gottardo and H. Dholaria and D. S.
Nørøxe and H. Goto and D. S. Ziegler and F. Y. Lin and D.
W. Parsons and H. Lindsay and T.-T. Wong and Y.-L. Liu and
K.-S. Wu and A. T. Franson and E. Hwang and A.
Aguilar-Bonilla and S. Cheng and C. Cacciotti and M.
Massimino and E. Schiavello and P. Wood and L. M. Hoffman
and A. Cappellano and A. Lassaletta and A. Van Damme and A.
Llort and N. U. Gerber and M. Spalato Ceruso and A. E.
Bendel and M. Skrypek and D. Hamideh and N. Mushtaq and A.
Walter and N. Jabado and A. Alsahlawi and J.-P. Farmer and
C. Coleman and S. Mueller and C. Mazewski and D. Aguilera
and N. J. Robison and K. O'Halloran and S. Abbou and P.
Berlanga and B. Geoerger and I. Øra and C. L. Moertel and
E. D. Razis and A. Vernadou and F. Ducray and C. Bronnimann
and R. Seizeur and M. Clarke and A. C. Resnick and M. Alves
and C. Jones and F. Doz and T. W. Laetsch and S. Perreault},
title = {{C}linical characteristics and outcome of central nervous
system tumors harboring {NTRK} gene fusions.},
journal = {Clinical cancer research},
volume = {31},
number = {3},
issn = {1078-0432},
address = {Philadelphia, Pa. [u.a.]},
publisher = {AACR},
reportid = {DKFZ-2024-02765},
pages = {561-572},
year = {2025},
note = {2025 Feb 3;31(3):561-572},
abstract = {TRK fusions are detected in less than $2\%$ of central
nervous system tumors. There are limited data on the
clinical course of affected patients.We conducted an
international retrospective cohort study of patients with
TRK fusion-driven CNS tumors.119 patients were identified.
The median age at time of diagnosis was 4.5 years. The
majority were reported to have a histology consistent with a
diagnosis of high-grade glioma (HGG) $(57.1\%)$ followed by
low-grade glioma (LGG) $(27.7\%).$ Pediatric patients had a
better prognosis with a median overall survival of 185.5
months compared to 24.8 months in adults (p<.0001). Patients
with LGG also had a better outcome when compared to HGG
(p=0.0012). The objective response was $68.8\%$ with
larotrectinib compared to $38.1\%$ for non-targeted
treatment.Children with LGG glioma had a favorable outcome
compared to adult and HGG. TRK inhibitors appear to improve
tumor control.},
cin = {B360},
ddc = {610},
cid = {I:(DE-He78)B360-20160331},
pnm = {312 - Funktionelle und strukturelle Genomforschung
(POF4-312)},
pid = {G:(DE-HGF)POF4-312},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:39625867},
doi = {10.1158/1078-0432.CCR-24-0581},
url = {https://inrepo02.dkfz.de/record/296022},
}